- Home
- BZUN vs BWAY Comparison
BZUN vs BWAY Comparison
Compare BZUN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- BWAY
- Stock Information
- Founded
- BZUN 2007
- BWAY 2003
- Country
- BZUN China
- BWAY Israel
- Employees
- BZUN N/A
- BWAY N/A
- Industry
- BZUN Catalog/Specialty Distribution
- BWAY Medical/Dental Instruments
- Sector
- BZUN Consumer Discretionary
- BWAY Health Care
- Exchange
- BZUN Nasdaq
- BWAY Nasdaq
- Market Cap
- BZUN 188.7M
- BWAY 177.4M
- IPO Year
- BZUN N/A
- BWAY 2019
- Fundamental
- Price
- BZUN $3.25
- BWAY $10.28
- Analyst Decision
- BZUN Strong Buy
- BWAY Strong Buy
- Analyst Count
- BZUN 3
- BWAY 3
- Target Price
- BZUN $3.20
- BWAY $13.17
- AVG Volume (30 Days)
- BZUN 427.0K
- BWAY 57.5K
- Earning Date
- BZUN 03-20-2025
- BWAY 03-05-2025
- Dividend Yield
- BZUN N/A
- BWAY N/A
- EPS Growth
- BZUN N/A
- BWAY N/A
- EPS
- BZUN N/A
- BWAY 0.04
- Revenue
- BZUN $1,312,737,613.00
- BWAY $38,631,000.00
- Revenue This Year
- BZUN $8.16
- BWAY $388.82
- Revenue Next Year
- BZUN $4.71
- BWAY $18.70
- P/E Ratio
- BZUN N/A
- BWAY $128.37
- Revenue Growth
- BZUN 7.26
- BWAY 34.19
- 52 Week Low
- BZUN $2.11
- BWAY $4.61
- 52 Week High
- BZUN $4.38
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- BZUN 58.19
- BWAY 46.35
- Support Level
- BZUN $3.05
- BWAY $10.24
- Resistance Level
- BZUN $3.43
- BWAY $10.89
- Average True Range (ATR)
- BZUN 0.17
- BWAY 0.47
- MACD
- BZUN 0.03
- BWAY -0.04
- Stochastic Oscillator
- BZUN 74.26
- BWAY 10.34
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.